Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

VersaPharm

VersaPharm
1994 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
6 FINANCING ROUNDS
2 INVESTMENTS
Description

Developer and marketer of specialty prescription products in the United States. The company offers pharmaceuticals primarily for the treatment areas of tuberculosis, hemophilia, anthrax, parkinsonism, blood disorders and other diseases. It supplies its products through public health departments, wholesale drug networks, managed care providers, hospitals, convalescent homes and retail pharmacies, as well as through federal, state, city and county governments.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 1775 West Oak Parkway
  • Suite 800
  • Marietta, GA 30062
  • United States

+1 (770) 000-0000

VersaPharm Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore VersaPharm‘s full profile, request access.

Request full access to PitchBook

VersaPharm Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 (000000 0 01-Aug-2012 0000000000 Other Pharmaceuticals and Biotechnology
Allan Pharmaceuticals (Generic Rx Division) 08-Dec-2008 Buyout/LBO Pharmaceuticals 00000 00000000
To view this company’s complete investment and acquisition history, request access »

VersaPharm Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore VersaPharm‘s full profile, request access.

Request full access to PitchBook

VersaPharm Executive Team (3)

Name Title Board
Seat
Contact
Info
Kevin Connelly Chief Executive Officer
Stephen McCune Chief Sales & Marketing Officer
Joseph Leary Chief Operating Officer